Загрузка страницы

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

We sit down with Alan Cannell, who has been a collaborator with TrialSite News down in Brazil and talk about treatments for Covid-19.
An engineer by training he is originally from the Isle Of Man between Scotland and Ireland and moved to Brazil IN THE 1970s and now has a family there. He has been applying his methodical engineering mindset to studying the trends of using Ivermectin at least at the local level in Brazil.

Видео Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41 канала To Be Frank
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
11 ноября 2020 г. 19:00:02
00:32:51
Другие видео канала
Clinical Trials and Research News Weekly Roundup | S2 E20Clinical Trials and Research News Weekly Roundup | S2 E20Dr. Ragan Discusses X4’s Work To Advance Disease-Modifying Therapies For Rare Genetic Diseases.Dr. Ragan Discusses X4’s Work To Advance Disease-Modifying Therapies For Rare Genetic Diseases.Interview with Dr. Michael Weiner about Alzheimer's Disease | S2 E08Interview with Dr. Michael Weiner about Alzheimer's Disease | S2 E08Rich Horgan: Why he Started "Cure Rare Disease" and Their Investigation in Customized TherapiesRich Horgan: Why he Started "Cure Rare Disease" and Their Investigation in Customized TherapiesThe Watchlist Series: David Vs Goliath, An Interview With Patrick Girondi | S1 - E04The Watchlist Series: David Vs Goliath, An Interview With Patrick Girondi | S1 - E04Investor Watch Series | Funding- Who to Watch | S1 E1Investor Watch Series | Funding- Who to Watch | S1 E1The Watchlist Series: Hope And Reality, The ongoing Coronavirus Story | S1 E08The Watchlist Series: Hope And Reality, The ongoing Coronavirus Story | S1 E08Clinical Trials and Research News Weekly Roundup | S2 E10Clinical Trials and Research News Weekly Roundup | S2 E10Jason Baumgartner of BEKHealth Talks About The Current State of Research Operations in a COVID WorldJason Baumgartner of BEKHealth Talks About The Current State of Research Operations in a COVID WorldControversial Clinical Trial Requires Patients Pay $1M  | S1 - E02Controversial Clinical Trial Requires Patients Pay $1M | S1 - E02Special Edition: Coronavirus RundownSpecial Edition: Coronavirus RundownDr. Abribat talks Amolyt Pharma: Advance therapeutic peptides treat endocrine and metabolic diseasesDr. Abribat talks Amolyt Pharma: Advance therapeutic peptides treat endocrine and metabolic diseasesClinical Trials and Research News Weekly Roundup | 12-09-2019 S1 E20Clinical Trials and Research News Weekly Roundup | 12-09-2019 S1 E20Clinical Trials and Research News Weekly Roundup | 11-04-2019 S1 E16Clinical Trials and Research News Weekly Roundup | 11-04-2019 S1 E16The Watchlist Series: Lawsuit Claims State Provider Transformed Research to Den of Iniquity | S1 E06The Watchlist Series: Lawsuit Claims State Provider Transformed Research to Den of Iniquity | S1 E06Dr. Pallavi Tiwari Talks About a GPS Map to Pinpoint Brain Tumors| Podcast S2 E15Dr. Pallavi Tiwari Talks About a GPS Map to Pinpoint Brain Tumors| Podcast S2 E15NYC Lifts Vaccine Mandate for Municipal Workers. But Lawsuits Remains over Back-pay, Lost JobsNYC Lifts Vaccine Mandate for Municipal Workers. But Lawsuits Remains over Back-pay, Lost JobsChristian Rubio Talks About Global Genes and Advocacy for Patients with Rare DiseasesChristian Rubio Talks About Global Genes and Advocacy for Patients with Rare DiseasesClinical Trials and Research News Weekly Roundup | 12-23-2019 S1 E22Clinical Trials and Research News Weekly Roundup | 12-23-2019 S1 E22Roseanne Onyia of Clinique Research Development Limited: Clinical Research in NigeriaRoseanne Onyia of Clinique Research Development Limited: Clinical Research in NigeriaThe Watchlist Series: Catch Me If You Can 1-3-2020 S1 E1The Watchlist Series: Catch Me If You Can 1-3-2020 S1 E1
Яндекс.Метрика